Xenon Pharmaceuticals Inc. Employee Directory
Biotechnology ResearchBritish Columbia, Canada201-500 Employees
Xenon Pharmaceuticals Inc. is a neuroscience-focused biotechnology company engaged in drug discovery, clinical development, and commercialization of therapeutics for patients in need. Headquartered in Burnaby, British Columbia, the company operates offices in Vancouver and Boston and employs between 201 and 500 people. Its lead candidate, azetukalner, is a novel Kv7 potassium channel opener in Phase 3 clinical trials for epilepsy, major depressive disorder, and bipolar depression. Xenon is developing an early-stage portfolio of potassium and sodium channel modulators, including Kv7 and Nav1.7 programs in Phase 1 development for potential pain indications. The company is positioned within the biotechnology research sector, pursuing neuroscience-focused therapies and maintaining ongoing clinical development activities.
1-888-653-2347 
support@leadiq.com 
